Collaborate Disseminate
A drug currently used as a second- or third-line treatment for those with rheumatoid arthritis has shown huge promise as a preventative, stopping the onset of the debilitating disease in 92.8% of at-risk participants after 12 months.
Tags: King’s College London, Arthritis, Rheumatoid arthritis, Pain, Joints, Inflammatory, Aging, Age-Related
Continue reading Existing jab offers “ray of hope” for preventing rheumatoid arthritis
‘Arthritis’ means inflammation or swelling of one or more joints, but more than 100 conditions affect the joints, the tissues around the joint, and other connective tissue. While symptoms vary depending on the type of arthritis, they commonly include d… Continue reading Body clocks, bacteria & a joint-on-a-chip: 2023’s best arthritis stories
They’ve been approved for the US market since 2012, but Janus kinase (JAK) inhibitors are still the new kid on the block in terms of rheumatoid arthritis treatment. As such, the real-world evidence on this class of drugs is scarce compared to establish… Continue reading Newer rheumatoid arthritis drugs work well in the real world
Injecting antibodies from a healthy person into someone suffering from rheumatoid arthritis can reduce inflammation and slow bone degeneration, but how this occurs has remained largely unknown until now. Researchers have uncovered the molecular pathway… Continue reading Molecular discovery may mean new treatments for rheumatoid arthritis
Autoimmune diseases affect almost four percent of the global population, the most common being Crohn’s disease, psoriasis, multiple sclerosis, and rheumatoid arthritis. A new study has identified a naturally occurring compound that may provide a new wa… Continue reading Discovery of compound with potential to treat autoimmune diseases
Instead of injections or pills, why not engineer bacteria to secrete therapeutic molecules from within our gut? A new study is demonstrating this futuristic idea, showing how a genetically modified probiotic can produce an experimental anti-inflammator… Continue reading Bacteria engineered to secrete rheumatoid arthritis drug in the body
Autoimmune diseases are a common health problem, and while system-wide immune suppression can help relieve symptoms, this can cause other complications. In a new study, scientists at Scripps Research developed nanoparticles that can selectively target … Continue reading Immune-regulating nanoparticles prevent arthritis in susceptible mice
Autoimmune diseases are a common health problem, and while system-wide immune suppression can help relieve symptoms, this can cause other complications. In a new study, scientists at Scripps Research developed nanoparticles that can selectively target … Continue reading Immune-regulating nanoparticles prevent arthritis in susceptible mice
A study published in the journal Arthritis & Rheumatology has provided new evidence gut bacteria plays a role in the development of rheumatoid arthritis. The research suggests an abnormal immune response to a relatively common species of gut bacteria c… Continue reading New evidence linking gut bacteria with rheumatoid arthritis development
Scientists studying the activity of a drug used to treat rheumatoid arthritis have discovered it has some surprising functions, some of which may be useful when it comes to countering diabetes. The research, carried out on mouse models, shows how the c… Continue reading Arthritis drug boosts fat-signaling and counters diabetes in obese mice